Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
NCT ID: NCT01615731
Last Updated: 2024-02-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2012-05-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks
NCT02679092
Cervical Preparation Before Dilation and Evacuation
NCT01751087
Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
NCT01436279
Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services
NCT01862991
Cervical Preparation With Mifepristone Prior to Osmotic Dilators
NCT03714880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Two sets of dilators
Two sets of osmotic dilators inserted 1 and 2 days pre-op
Hygroscopic cervical dilators
Dilapan-S osmostic cervical dilators inserted through the internal os
Misoprostol
400mcg buccal misoprostol 90 minutes pre-op
Intra-amniotic digoxin
1mg digoxin administered intra-amniotically \~24 hours pre-op
Mifepristone plus one set of dilators
One set of dilators plus mifepristone
Mifepristone
200mg Mifepristone orally
Hygroscopic cervical dilators
Dilapan-S osmostic cervical dilators inserted through the internal os
Misoprostol
400mcg buccal misoprostol 90 minutes pre-op
Intra-amniotic digoxin
1mg digoxin administered intra-amniotically \~24 hours pre-op
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mifepristone
200mg Mifepristone orally
Hygroscopic cervical dilators
Dilapan-S osmostic cervical dilators inserted through the internal os
Misoprostol
400mcg buccal misoprostol 90 minutes pre-op
Intra-amniotic digoxin
1mg digoxin administered intra-amniotically \~24 hours pre-op
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Viable, Singleton pregnancy
* Voluntarily seeking abortion between 19 and 24wks gestation
* Able to give informed consent and comply with study protocol
* Fluent in English or Spanish
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santa Clara Valley Medical Center
OTHER
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Santa Clara Valley Medical Center
San Jose, California, United States
Stanford University Medical Center
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-05302012-10088
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.